**Specification TableSubject Area**:Pharmacology, Toxicology and Pharmaceutical Science**More specific subject area:***In vitro* Cellular Toxicology**Protocol name:**Three-step protocol to dissolve 3-MCPD esters and free fatty acids in aqueous cell culture media**Reagents/tools:Reagents:**\
Dimethylsulfoxide (DMSO; Sigma, St. Louis, MO)\
Acetonitrile (Sigma, St. Louis, MO)\
2-propanol (Sigma, St. Louis, MO)\
Ethanol (Sigma, St. Louis, MO)\
Hyclone fetal bovine serum (FBS; Invitrogen, Carlsbad, CA)\
CellTiter-Glo® Luminescent Cell Viability Assay (Promega, Madison, WI)\
3-Monochloropropane-1,2-diol (3-MCPD; Toronto Research Chemicals, Toronto, Canada)\
1-Palmitoyl-3-chloropropanediol (1-Pa; Toronto Research Chemicals, Toronto, Canada)\
1-Linoleoyl-3-chloropropanediol (1-Li; Toronto Research Chemicals, Toronto, Canada)\
1-Oleoyl-3-chloropropanediol (1-Ol; Toronto Research Chemicals, Toronto, Canada)\
1-Palmitoyl-2-linoleoyl-3-chloropropanediol (Pa-Li; Toronto Research Chemicals, Toronto, Canada)\
1-Palmitoyl-2-oleoyl-3-chloropropanediol (Pa-Ol; Toronto Research Chemicals, Toronto, Canada)\
1-Oleoyl-2-linoleoyl-3-chloropropanediol (Ol-Li; Toronto Research Chemicals, Toronto, Canada)\
1,2-Di-palmitoyl-3-chloropropanediol (Pa-Pa; Toronto Research Chemicals, Toronto, Canada)\
1,2-Di-oleoyl-3-chloropropanediol (Ol-Ol; Toronto Research Chemicals, Toronto, Canada)\
1,2-Di-linoleoyl-3-chloropropanediol (Toronto Research Chemicals, Toronto, Canada)\
Palmitic Acid (Pa; Toronto Research Chemicals, Toronto, Canada)\
Oleic Acid (Ol; Toronto Research Chemicals, Toronto, Canada)\
Linoleic Acid (Li; Toronto Research Chemicals, Toronto, Canada)\
Human Kidney HK-2 Cell Line (ATCC, Manassas, VA)\
Keratinocyte SFM (Invitrogen, Carlsbad, CA)\
**Tools:**\
Fluostar Omega plate reader (BMG LabTech, Cary, NC)\
ACCU-SCOPE 3030 & 3030 PH inverted microscope with 10x Plan Phase, NA 0.25, WD 8.0 mm (Commack, NY)\
Eppendorf tubes (Eppendorf, Hamburg, Germany)\
Heat mat (Brisk, Columbus, OH)\
Isotemp hot plate (Fisher Scientific, Hampton, NH)\
Water bath (Fisher Scientific, Hampton, NH)\
Micro-pipettors with capacities of 2-1000 ul (Eppendorf, Hamburg, Germany)**Experimental design:**A range of concentrations of organic solvents was prepared in cell culture media and added to human epithelial cells of kidney origin (HK-2 cell line) cultured in vitro for 24 hours at 37 °C/5% CO~2~. Cell viability was measured to identify solvent conditions that are nontoxic and the selected solvent was used to develop a cost-effective three-step protocol to easily dissolve hydrophobic compounds like 3-MCPD esters and free fatty acids that are relevant to the field of toxicology.**Trial registration:**Not applicable**Ethics:**Not applicable

**Value of the Protocol**•Having a protocol to easily dissolve hydrophobic compounds such as 3-MCPD esters and free fatty acids into aqueous cell culture medium is valuable for its downstream applications. Once compounds are rendered soluble in cell culture media, then a plethora of *in vitro* cellular toxicology assays can be performed to evaluate their potential toxicity levels and mechanisms of action. Such evaluations are especially important for establishing *in vitro* to *in vivo* concordance in the field of predictive toxicology.

Background {#se0155}
==========

Successful *in vitro* cellular toxicity testing is predicated on how easily and stably test compounds can dissolve into cell culture media, but when compounds are inherently hydrophobic or non-polar, then dissolving them into aqueous media limits their achievable concentration range. Ester derivatives of 3-monochloropropane-1,2-diol (3-MCPD) are low-level contaminants found in infant formula \[[@bib0005],[@bib0010]\] and have been shown in rodents to be toxic to the renal, testicular, and nervous systems \[[@bib0015], [@bib0020], [@bib0025], [@bib0030]\]. They are too hydrophobic to easily dissolve into cell culture media and the use of organic solvents to solubilize these hydrophobic compounds is limited by the solvents inherent toxicity to mammalian cells. In our attempts to circumvent these limitations, we established a simple three-step protocol to overcome their immiscibility in human epithelial cells of kidney origin (HK-2) cell culture medium and thus enable *in vitro* cellular toxicity testing.

Organic solvent pre-screening {#sec0005}
=============================

Although organic solvents are generally very toxic to mammalian cells, they have been useful in many cases to help dissolve hydrophobic compounds, such as free fatty acids \[[@bib0035], [@bib0040], [@bib0045]\]. We hypothesized that their cellular toxicity could be mitigated by (a) careful selection of the organic solvent and (b) using very low concentrations on cells. We selected ethanol, 2-propanol, acetonitrile, and dimethylsulfoxide (DMSO) as four candidate organic solvents (all from Sigma, St. Louis, MO). We then tested the toxicity of each one at concentrations ranging from 0 to 10% (v/v) in HK-2 cell culture media (Keratinocyte media supplemented with 10% fetal bovine serum, 0.3% bovine pituitary extract, and 2.5 ng/ml of epidermal growth factor; Invitrogen, Carlsbad, CA). Following the manufacturer's instructions, we measured HK-2 cell viability following a 24 -h exposure to each solvent using the CellTiter-Glo® Luminescent Cell Viability Assay (Promega, Madison, WI). Luminescent signal representing cell viability levels were measuring using the Fluostar Omega plate reader (BMG LabTech, Cary, NC). As shown in [Fig. 1](#fig0005){ref-type="fig"}, we found that HK-2 cells could be cultured without inducing significant loss of cell viability in the presence of all tested solvents if, these solvents comprised approximately 1% (v/v) of the cell culture medium. For solvent levels above 1%, only acetonitrile and DMSO in cell culture medium for 24 h at 37 °C/5%CO~2~ could maintain basal cell viability. DMSO, however, is better suited for use in cell culture systems than acetonitrile because its vapor pressure at 20 °C is much lower (DMSO: 0.417 mm Hg *vs*. acetonitrile: 72.8 mm Hg) \[[@bib0050],[@bib0055]\], making it considerably less volatile and easier to work with.Fig. 1Relative percentages of cell viability levels of human kidney HK-2 cells in 0--10% (v/v) organic solvents following exposure for 24 h at 37 °C/5%CO~2~.Fig. 1

Three-step solubilization protocol for 3-MCPD esters {#sec0010}
====================================================

Hydrophobic compound solutions in aqueous media are often performed in a two-step manner, wherein compounds of interest are dissolved into an organic solvent and subsequently diluted in aqueous media to reduce the organic solvent concentration down to 1% or less \[[@bib0035], [@bib0040], [@bib0045]\]. However, some compounds, such as 3-MCPD esters, are not amenable to this protocol; instead of completely dissolving, they undergo 'hydrophobic effects' \[[@bib0060]\] and precipitate out as globules/spheres/droplets of varying sizes. This effect was verified using several compounds (all from Toronto Research Chemicals, Toronto, Canada): nine esters of 3-MCPD, including three mono-esters of 3-MCPD (1-Pa, 1-Li, and 1-Ol), six di-esters of 3-MCPD (Pa-Li, Pa-Ol, Ol-Li, Pa-Pa, Li-Li, and Ol-Ol), and three free fatty acids (Pa, Li, and Ol). As shown in [Fig. 2](#fig0010){ref-type="fig"}A, whereas light microscopy images of PBS, cell culture media, and water-soluble free 3-MCPD were free of droplet precipitate, the majority of 3-MCPD esters and free fatty acids contained obvious droplets or globules of various sizes. It should be noted that although this two-step method could not achieve good solubility outcomes for all tested compounds, a few of their 100 μM solutions (1-Pa, Pa-Li, and Pa) exhibited only small droplets, rather than large globules of precipitate ([Fig. 2](#fig0010){ref-type="fig"}A). When evaluating the effects of any solution on cells, it is best to achieve the most homogenous and finest stable solute emulsion possible across all compounds undergoing toxicological evaluation. Having large globules or droplets is not ideal for *in vitro* cellular toxicity assays, since differences in solubility between compounds would translate to insufficient and/or inconsistent exposures, which in turn would confound the interpretation of toxicological data.Fig. 2Light microscopy images at 10× magnification of 100 μM test compound stock solutions prepared using the common two-step (A) or newly developed three-step protocol (B) with final solvent concentrations of 1% DMSO in HK-2 cell culture medium.Fig. 2

To overcome this unwanted effect, a three-step solubilization protocol was developed to achieve stable homogenous solutions of each compound of interest.

**Step 1**: Prepare 10 mM stock solutions of each compound of interest in pure DMSO (Sigma, St. Louis, MO) at room temperature. In some cases, if a compound is unusually immiscible, briefly vortex it at the maximum setting for five seconds in DMSO, then warm it to 37 °C in a water bath before moving on to the next step of the protocol.

**Step 2**: Dilute all compounds by10-fold using fetal bovine serum that has been pre-warmed to ∼50 °C in a water bath. Keep all solutions warm using a Brisk heat pad set to ∼40 °C.

**Step 3**: Perform a final dilution in pre-warmed cell culture media (containing only 1% FBS) to achieve a final test compound concentration of 100 μM.

To verify the success of this three-step protocol, we prepared 100 μM solutions of the same 13 compounds that had previously been shown in [Fig. 2](#fig0010){ref-type="fig"}A to have solubility issues using the conventional two-step method. As shown in [Fig. 2](#fig0010){ref-type="fig"}B, when we imaged each of the 13 solutions, we found that the three-step protocol achieved excellent solubility in aqueous cell culture media. Notably, only Pa-Pa needed to be briefly vortexed at step 1 and warmed to 37 °C in a water bath before moving on to step 2 of the protocol. Using this three-step protocol, our research group has been able to perform comprehensive *in vitro* cellular toxicological evaluations of the effects of these compounds of interest \[[@bib0065]\]. Prior to the creation of this protocol, however, the lack of 3-MCPD ester solubility hampered *in vitro* cellular studies until now. We expect that its continued application to the field of *in vitro* cellular toxicology will allow other researchers to evaluate a great number of hydrophobic compounds that need to be evaluated for toxicity and mechanistic effects relevant to human health and disease.
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